17:33 EST TuHURA Biosciences (HURA) files $250M mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HURA:
- TuHURA Biosciences Plans Phase 2 Trial for TBS-2025
- TuHURA Biosciences Secures $3M Bridge Loan Agreement
- Tuhura Biosciences Advances in Merkel Cell Carcinoma Treatment Study
- Tuhura Biosciences’ Promising Phase 1 Trial: A Potential Game-Changer in Merkel Cell Carcinoma Treatment
- TuHURA Biosciences Extends Warrant Expiration to 2030